Literature DB >> 14607792

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study.

Manjit S Matharu1, Thorsten Bartsch, Nick Ward, Richard S J Frackowiak, Richard Weiner, Peter J Goadsby.   

Abstract

Electrical stimulation of primary sensory afferents is known to have an antinociceptive effect. Animal and functional imaging studies suggest a role for supraspinal structures in this response. Eight patients with chronic migraine (> or =15 days per month of attacks of migraine without aura), who had shown a marked beneficial response to implanted bilateral suboccipital stimulators, were studied. Stimulation evoked local paraesthesia, the presence of which was a criterion of pain relief. On stimulation, the headache began to improve instantaneously and was completely suppressed within 30 min. On switching off the stimulation, the headache recurred instantly and peaked within 20 min. PET scans were performed using regional cerebral blood flow (rCBF) as a marker of neuronal activity. Each patient was scanned in the following three states: (1) stimulator at optimum settings: patient pain-free but with paraesthesia; (2) stimulator off: patient in pain and no paraesthesia; (3) stimulator partially activated: patient with intermediate levels of pain and paraesthesia. All scans were processed and analysed using Statistical Parametric Mapping (SPM) 99. There were significant changes in rCBF in the dorsal rostral pons, anterior cingulate cortex (ACC) and cuneus, correlated to pain scores, and in the ACC and left pulvinar, correlated to stimulation-induced paraesthesia scores. The activation pattern in the dorsal rostral pons is highly suggestive of a role for this structure in the pathophysiology of chronic migraine. The localization and persistence of activity during stimulation is exactly consistent with a region activated in episodic migraine, and with the persistence of activation of that area after successful treatment. The dorsal rostral pons may be a locus of neuromodulation by suboccipital stimulation. In addition, suboccipital stimulation modulated activity in the left pulvinar.

Entities:  

Mesh:

Year:  2003        PMID: 14607792     DOI: 10.1093/brain/awh022

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  104 in total

Review 1.  Cortical excitability in chronic migraine.

Authors:  Gianluca Coppola; Jean Schoenen
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 3.  Surgical treatment of primary headaches.

Authors:  Angelo Franzini; Giuseppe Messina; Roberto Cordella; Alberto Proietti Cecchini; Massimo Leone; Gennaro Bussone
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 4.  Deep brain stimulation in cluster headache: hypothalamus or midbrain tegmentum?

Authors:  Manjit S Matharu; Ludvic Zrinzo
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 5.  Occipital nerve stimulation for headache disorders.

Authors:  Koen Paemeleire; Thorsten Bartsch
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

6.  Headache.

Authors:  Peter J Goadsby
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

7.  Occipital nerve stimulation in primary headache syndromes.

Authors:  Giorgio Lambru; Manjit S Matharu
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 8.  Emerging therapies for chronic migraine.

Authors:  Alberto Proietti Cecchini; Licia Grazzi
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 9.  Headache frontiers: using magnetoencephalography to investigate pathophysiology of chronic migraine.

Authors:  Wei-Ta Chen; Yung-Yang Lin; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2013-01

Review 10.  [The trigemino-cervical complex. Integration of peripheral and central pain mechanisms in primary headache syndromes].

Authors:  V Busch; A Frese; T Bartsch
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.